CANCER CAPITAL CORP
company.status.inactiveCIK 1130889fmd_0R24BDJ7JY2QPCFRM2JAHFE11AFinance, Insurance and Real Estate · Blank ChecksTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2024, 58 periods
Latest annual · FY2023
Millions- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q3 FY2024
Millions- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2018 to FY2023
- n/m
CANCER CAPITAL CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Operating income | -$14,897 | -$21,008 | 10-K 2024-04-15 · proof | |
| Net income | -$37,792 | -$42,467 | 10-K 2024-04-15 · proof | |
| Cash from operating activities | -$8,897 | -$15,008 | 10-K 2024-04-15 · proof | |
| Total assets | $16,157 | $22,055 | -26.7% | 10-K 2024-04-15 · proof |
| Total liabilities | $465,549 | $433,654 | +7.4% | 10-K 2024-04-15 · proof |
| Cash and cash equivalents | $16,157 | $22,054 | -26.7% | 10-K 2024-04-15 · proof |
- What was CANCER CAPITAL CORP's operating income in fiscal 2023?
- CANCER CAPITAL CORP reported operating income of -$14,897 for fiscal 2023 (the year ended Dec 31, 2023), against -$21,008 the year before. Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
- What was CANCER CAPITAL CORP's net income in fiscal 2023?
- CANCER CAPITAL CORP reported net income of -$37,792 for fiscal 2023 (the year ended Dec 31, 2023), against -$42,467 the year before. Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
- What was CANCER CAPITAL CORP's cash from operating activities in fiscal 2023?
- CANCER CAPITAL CORP reported cash from operating activities of -$8,897 for fiscal 2023 (the year ended Dec 31, 2023), against -$15,008 the year before. Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
- What are CANCER CAPITAL CORP's total assets?
- As of Dec 31, 2023, CANCER CAPITAL CORP reported total assets of $16,157, against $22,055 a year earlier (-26.7%). Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
- What are CANCER CAPITAL CORP's total liabilities?
- As of Dec 31, 2023, CANCER CAPITAL CORP reported total liabilities of $465,549, against $433,654 a year earlier (+7.4%). Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
- What are CANCER CAPITAL CORP's cash and cash equivalents?
- As of Dec 31, 2023, CANCER CAPITAL CORP reported cash and cash equivalents of $16,157, against $22,054 a year earlier (-26.7%). Source: the 10-K filed with the SEC on Apr 15, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1130889&period_type=annual&limit=5"Information only, not investment advice.